Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Catheterization and Cardiovascular Diagnosis|January 1, 1991
Accuracy and reproducibility of quantitative coronary arteriography using 6 and 8 French catheters with cine angiographic acquisitionS G Ellis, I M Pinto, M J McGillem, et al.
American Heart Journal|August 1, 1989
Comparison of coronary angioplasty with medical treatment for single- and double-vessel coronary disease with left anterior descending coronary involvement: long-term outcome based on an Emory-CASS registry studyS G Ellis, L Fisher, S Dushman-Ellis, et al.
Journal of the American College of Cardiology|March 25, 2000
Abciximab reduces mortality in diabetics following percutaneous coronary interventionD L Bhatt, S P Marso, A M Lincoff, et al.
Journal of the American College of Cardiology|February 11, 1999
Effect of age on outcome with primary angioplasty versus thrombolysisD R Holmes, H D White, K S Pieper, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 1, 1997
A profile of candidates for repeat myocardial revascularization: implications for selection of treatmentS J Brener, F D Loop, B W Lytle, et al.
Coronary Artery Disease|February 1, 1993
Early reocclusion after successful thrombolysis is related to lesion length and roughnessN B de Cesare, S G Ellis, P R Williamson, et al.
The American Journal of Cardiology|September 1, 1988
Presentation and late outcome of myocardial infarction in the absence of angiographically significant coronary artery diseaseM J Pecora, G S Roubin, B W Cobbs, et al.
Journal of the American College of Cardiology|April 8, 1999
The importance of proteinuria as a determinant of mortality following percutaneous coronary revascularization in diabeticsS P Marso, S G Ellis, M Tuzcu, et al.
Circulation|August 15, 1995
In-hospital cost of percutaneous coronary revascularization. Critical determinants and implicationsS G Ellis, D P Miller, K J Brown, et al.
The American Journal of Cardiology|September 1, 1988
Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trialE J Topol, J M Nicklas, N H Kander, et al.
Pageof 19